These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18056945)

  • 1. Stability of codeine phosphate in an extemporaneously compounded syrup.
    Dentinger PJ; Swenson CF
    Am J Health Syst Pharm; 2007 Dec; 64(24):2569-73. PubMed ID: 18056945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
    Dentinger PJ; Swenson CF
    Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
    Caruthers RL; Johnson CE
    Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1998 Sep; 55(18):1915-20. PubMed ID: 9784772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of nifedipine in an extemporaneously compounded oral solution.
    Dentinger PJ; Swenson CF; Anaizi NH
    Am J Health Syst Pharm; 2003 May; 60(10):1019-22. PubMed ID: 12789873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of ganciclovir in extemporaneously compounded oral liquids.
    Anaizi NH; Swenson CF; Dentinger PJ
    Am J Health Syst Pharm; 1999 Sep; 56(17):1738-41. PubMed ID: 10512505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of mycophenolate mofetil in an extemporaneously compounded oral liquid.
    Anaizi NH; Swenson CF; Dentinger PJ
    Am J Health Syst Pharm; 1998 May; 55(9):926-9. PubMed ID: 9588251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of norfloxacin in an extemporaneously prepared oral liquid.
    Johnson CE; Price J; Hession JM
    Am J Health Syst Pharm; 2001 Apr; 58(7):577-9. PubMed ID: 11296605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of dolasetron in two oral liquid vehicles.
    Johnson CE; Wagner DS; Bussard WE
    Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of extemporaneously prepared rifaximin oral suspensions.
    Cober MP; Johnson CE; Lee J; Currie K
    Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP; Johnson CE; Sudekum D; Penprase K
    Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of levofloxacin in an extemporaneously compounded oral liquid.
    VandenBussche HL; Johnson CE; Fontana EM; Meram JM
    Am J Health Syst Pharm; 1999 Nov; 56(22):2316-8. PubMed ID: 10582824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension.
    Atkins JR; Lull ME; Decker AS; Hutchinson DJ
    Int J Pharm Compd; 2018; 22(4):326-328. PubMed ID: 30021187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and stability of an extemporaneously compounded oral solution of chlorpromazine HCl.
    Prohotsky DL; Juba KM; Zhao F
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):367-70. PubMed ID: 25338106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(18):2179-84. PubMed ID: 8879325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of tacrolimus in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; West NJ; Foster JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneously prepared oxandrolone oral suspensions.
    Johnson CE; Cober MP; Hawkins KA; Julian JD
    Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.